XML 57 R40.htm IDEA: XBRL DOCUMENT v3.25.0.1
VENTURE CAPITAL AND STRATEGIC EQUITY INVESTMENTS (Tables)
 12 Months Ended
Dec. 28, 2024
Equity Method Investments and Joint Ventures [Abstract]  
Schedule of Equity Method Investments
Venture capital investments are summarized below:
December 28, 2024December 30, 2023December 31, 2022
(in thousands)
Beginning balance$121,158 $129,012 $149,640 
Capital contributions22,063 17,410 14,485 
Distributions(23,023)(15,685)(9,861)
Gain (loss)(2,753)(10,263)(24,398)
Foreign currency translation(884)684 (854)
Ending balance$116,561 $121,158 $129,012 
The Company also invests, with minority positions, directly in equity of predominantly privately held companies. Strategic investments are summarized below:
December 28, 2024December 30, 2023December 31, 2022
(in thousands)
Beginning balance$122,653 $182,590 $51,712 
Purchase of investments6,421 34,028 142,477 
Distributions(6,432)(9,381)(2,732)
Gain (loss) (1)
(19,935)108,090 (2,377)
Reduction for acquisition of entities (1)
— (197,753)— 
Foreign currency translation(918)5,079 (6,490)
Ending balance$101,789 $122,653 $182,590 
(1) Refer to Note 2 – Acquisitions and Divestitures for further discussion of the 2023 Noveprim and SAMDI acquisitions.